- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Can Lilly afford to maintain its dividend?
April 17, 2010
J.K. WallAs shareholders gather April 19 for Eli Lilly and Co.'s annual meeting, more of them than ever will come with an unusual question:
Will Lilly be able to keep paying its dividend?
MoreLilly sets date for move from Faris campus downtown
April 12, 2010
Work force reductions, new business structure make leased office space unnecessary. Moves will begin in late June.
MoreLilly diabetes drug may have cancer risk, FDA says
April 9, 2010
IBJ Staff and Bloomberg NewsOnce-weekly form of Byetta is awaiting the FDA's OK. Analyst predict the new version of the drug, if approved, could rack
up sales of $2 billion annually.
MoreLouisiana gets $20M in Lilly drug settlement
April 7, 2010
Associated PressLouisiana was one of 13 states that filed individual suits in state courts over allegations that Lilly pushed Zyprexa for
uses that had not been approved by federal regulators.
MoreLilly wins court ban on generic copy of Gemzar
April 1, 2010
Bloomberg News, Associated PressEli Lilly and Co. won a U.S. court ruling Wednesday that bars Teva Pharmaceutical Industries Ltd. from selling a generic version
of the cancer drug Gemzar until November.
MoreLilly drug wins U.K. backing as cancer therapy
April 1, 2010
Bloomberg NewsEli Lilly and Co.'s Alimta has received the preliminary backing of a United Kingdom agency as a maintenance treatment for
patients with the most common form of lung cancer.
MoreLilly to let 115 workers go in new outsourcing deal
March 26, 2010
J.K. WallDeal with unit of Massachusetts-based Thermo Fisher Scientific would keep many of the employees working in same
location.
MoreLilly eyes more animal-health acquisitions
March 25, 2010
IBJ Staff and Bloomberg NewsEli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.'s plan to
combine their veterinary units.
MoreLilly sues Hospira over generic version of Gemzar
March 24, 2010
Bloomberg NewsIndianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.
MoreLilly Endowment's assets drop more than foundation peers
March 24, 2010
Andrea Muirragui DavisOnce the nation’s wealthiest foundation, Indianapolis-based Lilly Endowment now ranks ninth among its grant-making
peers. The endowment’s value fell 15 percent last year, to an estimated $4.8 billion.
MoreBill kicks off years of change for local health care players
March 22, 2010
J.K. WallSweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.
MoreLilly sues to block generic of Adcirca lung treatment
March 17, 2010
Bloomberg NewsNetherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
MoreLilly victim of theft from Connecticut warehouse
March 16, 2010
IBJ Staff and Associated PressPharmaceuticals stolen Sunday morning could be worth up to $75 million.
MoreLilly pays $50M-plus for rights to testosterone lotion
March 16, 2010
Bloomberg NewsIndianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing
assets are transferred, but the deal could be worth millions more.
MoreFDA says 'not yet' on Lilly's once-weekly Byetta
March 15, 2010
J.K. WallRegulators won't require more time-consuming tests of the drug, but want Eli Lilly and Co. and its partners to clarify labeling,
manufacturing
processes.
MoreEli Lilly to buy European rights to Pfizer animal products
March 8, 2010
Scott OlsonThe acquisition will benefit Elanco, Lilly's animal health division in Greenfield, which has become increasingly important
to Lilly as it braces for patent-protection losses.
MoreMarket surge doesn't lift Lilly Endowment
March 6, 2010
Kathleen McLaughlinLilly Endowment's resistance to diversify its holdings reached a new height last year, as it failed to sell a single share
of the underperforming Eli Lilly and Co. stock while the broader market surged.
MoreThree Indiana companies among world's most admired
March 5, 2010
Brightpoint, WellPoint and Cummins are recognized by Fortune magazine as being among the best in their industries.
MoreCornelius to retire as Bristol-Myers Squibb CEO
March 3, 2010
IBJ Staff and Associated PressThe former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
MoreTo attack costs, Lilly accelerates R&D
March 3, 2010
J.K. WallWith President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep
getting higher for Eli Lilly and Co.'s efforts to develop drugs faster and cheaper.
MoreLilly to shift more employees to Covance
February 26, 2010
J.K. WallGreenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
MoreObama health reform plan slaps drugmakers
February 24, 2010
J.K. WallDrugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals
with generic competitor.
MoreLilly, Merck, Pfizer starting research center
February 23, 2010
Associated PressThree major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
MoreWellPoint gets tax delay in Obama health plan
February 22, 2010
Bloomberg NewsInsurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
MoreLilly asks shareholders to lower takeover barrier
February 20, 2010
J.K. WallEli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Can IBJ please stop referring to this property as "Kessler Mansion"? What a ridiculous title for the biggest, bloated, blight in our city. It's not a mansion. At best, it's an ideal site to shoot low-budget porn. Ahhh! Another business use!
Its stories like these that prove that a Ball State diploma is worth less than the paper that its printed on. A real institution of higher learning would have taken care of this long ago. No way should this crap be taught in a SCIENCE class.
It is such a shame that King Ballard has made Indianapolis into Chicago south with all of the rampant corruption.
How many of these 1,259 bills were actually heard and voted on on the floor vs how many were shot down in committee?
When a an arrogant young guy with essentially no experience and no qualifications for the job, was dropped into an Administrator position out of nowhere by his "mentor" in the Mayor's office things seemed fishy. Sometimes things are what they seem.